Artemisinin drugs: novel antimalarial agents

Bibliography

• QINGHAOSU ANTIMALARIA CO-ORDINATING GROUP:Antimalaria studies on Qinghaosu. Chin. Med. J. (1979) 92:811–816.
   PubMed Web of Science ®Google Scholar
• HIEN TT, WHITE NJ: Qinghaosu. Lancet (1993)341:603–608.
   PubMed Web of Science ®Google Scholar
• CUMMING JN, PLOYPRADITH P, POSNER GH: Antima-larial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Adv. Pharmacol (1997) 37:253–297.
   PubMedGoogle Scholar
• HAYNES RK, VONWILLER SC: Extraction of artemisininand artemisinic acid: preparation of artemether and new analogues. Trans. R. Soc. Trop. Med. Hyg. (1994) 88 (Suppl. 1):S23–26.
   Google Scholar
• MESHNICK SR: Artemisinin antimalarials: mechanismsof action and resistance. Med. Trop. (1998) 58:13–17.
   PubMedGoogle Scholar
• CHINA CO-OPERATIVE RESEARCH GROUP: The chemistry and synthesis of qinghaosu derivatives. J. Tradit. Chin. Med. (1982) 2:9–16.
   PubMedGoogle Scholar
• LI GQ, GUO XB, YANG F: Clinical trials on qinghaosu and its derivatives. (1990) Trans. R. Soc. Trop. Med. Hyg. 88 (Suppl 1):S5–56.
   Google Scholar
• ALIN MH, BJORKMAN A: Concentration and time dependency of artemisinin efficacy against Plasmo-dium falciparum in vitro. Am. J. Trop. Med. Hyg. (1994) 50:771–776.
   PubMed Web of Science ®Google Scholar
• TER KUILE F, WHITE NJ, HOLLOWAY P, PASVOL G,KRISHNA S: Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp. Parasitol. (1993) 76:85–95.
   PubMed Web of Science ®Google Scholar
• UDOMSANGPETCH R, PIPITAPORN B, KRISHNA S et al: Andrugs reduce cyto adherence and rosetting Plasmodium falciparum. J. Infect. Dis. (1996) 173:691–698.
   PubMed Web of Science ®Google Scholar
• WHITE N: Clinical pharmacokinetics and pharmacody-namics of artemisinin and derivatives. Trans. R. Soc. Trop. Med. Hyg. (1994) 88 (Suppl. 1):S41–43.
   Google Scholar
• KYLE DE, TEJA-ISAVADHARM P, LI Q, LEO K: Pharma-cokinetics and pharmacodynamics of qinghaosu derivatives: how do they impact on the choice of drug and the dosage regimens? Med. Trop. (1998) 58:38–44.
   Google Scholar
• NAVARATNAM V, MANSOR SM, CHIN LK, MORDI MN, ASOKAN M, NAIR NK: Determination of artemether and dihydroartemisinin in blood plasma by high-performance liquid chromatography for application in clinical pharmacological studies. J. Chromatogr. B. Biomed. Appl. (1995) 669:289–294.
   PubMed Web of Science ®Google Scholar
• BENAKIS A, PARIS M, LOUTAN L, PLESSAS CT, PLESSAS ST: Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers. Am. J. Trop. Med.. Hyg. (1997) 56:17–23.
   PubMed Web of Science ®Google Scholar
• TEJA-ISAVADHARM P, NOSTEN F, KYLE DE et al.: Comparative bioavailability of oral, rectal and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay. Br. J. Clin. Pharmacol. (1996) 42:599–604.
   PubMed Web of Science ®Google Scholar
• NEWTON P, SUPUTTAMONGKOL Y, TEJA-ISAVADHARMP et al.: Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria. Antimicrob. Agents Chemother. (2000) 44:972–977.
   PubMed Web of Science ®Google Scholar
• BETHELL DB, TEJA-ISAVADHARM P, CAO XT et al: Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. (1997) 91:195–198.
   PubMed Web of Science ®Google Scholar
• LEE IS, HUFFORD CD: Metabolism of antimalarialsesquiterp en e lacton es. Pharmacol. Ther. (1990) 48:345–355.
   PubMed Web of Science ®Google Scholar
• BARRADELL LB, FITTON A: Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs (1995) 50:714–741.
   Google Scholar
• TITULAER HA, ZUIDEMA J, KAGER PA, WETSTEYN JC, LUGT CB, MERKUS FW: The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers. J. Pharm. Pharmacol. (1990) 42:810–813.
   PubMed Web of Science ®Google Scholar
• DUC DD, DE VRIES FJ, NGUYEN XK, LE NGUYEN B, KAGER PA, VAN BOXTEL CJ: The pharmacokinetics of a single dose of artemisinin in healthy Vietnamese subjects. Am. J. Trop. Med. Hyg. (1994) 51:785–790.
   PubMed Web of Science ®Google Scholar
• ALIN MH, ASHTON M, KIHAMIA CM, MTEY GJ, BJORKMAN A: Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria. Br. J Pharmacol. (1996) 41 :587–592.
   Web of Science ®Google Scholar
• NA BANGCHANG K, KARBWANG J, THOMAS CG et al: Pharmacokinetics of artemether after oral administra-tion to healthy Thai males and patients with acute, uncomplicated falciparum malaria. Br. J. Clin. Pharmacol. (1994) 37:249–253.
   PubMed Web of Science ®Google Scholar
• ITTARAT W, LOOAREESUWAN S, POOTRAKUL P, SUMPUNSIRIKUL P, VATTANAVIBOOL P, MESHNICK SR: Effects of alpha-thalassemia on pharmacokinetics of the antimalarial agent artesunate. Antimicrob. Agents Chemother. (1998) 42:2332–2335.
   PubMed Web of Science ®Google Scholar
• DE VRIES PJ, TRAN KD, NGUYEN XK et al.: The pharma-cokinetics of a single dose of artemisinin in patients with uncomplicated falciparum malaria. Am. J Trop. Med. Hyg. (1997) 56:503–507.
   PubMed Web of Science ®Google Scholar
• HASSAN ALIN M, ASHTON M, KIHAMIA CM, MTEY GJ, BJORKMAN A: Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans. R. Soc. Trop. Med. Hyg. (1996) 90:61–65.
   PubMed Web of Science ®Google Scholar
• SVENSSON US, ASHTON M: Identification of the humancytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. Br]. Clin. Pharmacol (1999) 48:528–535.
   PubMed Web of Science ®Google Scholar
• WHITE NJ, KRISHNA S: Treatment of malaria: someconsiderations and limitations of the current methods of assessment. Trans. R. Soc. Trop. Med. Hyg. (1989) 83:767–777.
   PubMed Web of Science ®Google Scholar
• LI GQ, ARNOLD K, GUO XB, JIAN HX, FU LC: Randomised comparative study of mefloquine, qinghaosu and pyrimethamine-sulfadoxine in patients with falciparum malaria. Lancet (1984) 2:1360–1361.
   PubMed Web of Science ®Google Scholar
• MYINT PT: Comparative study of Artemether versus standard antimalarials in Plasmodium Falciparum. Burmese Med. J. (1985) 2:36–43.
   Google Scholar
• LI GQ, GUO XB, FU LC, JIAN HX, WANG XH: Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans. R. Soc. Trop. Med. Hyg. (1994) 88 (Suppl. 1):S5–6.
   Google Scholar
• LOOAREESUWAN S, WILAIRATANA P, VANIJANONTA S, PITISUTTITHUM P, RATANAPONG Y, ANDRIAL M: Monotherapy with sodium artesunate for uncompli-cated falciparum malaria in Thailand: a comparison of 5-and 7-day regimens. Acta Trop. (1997) 67:197–205.
   PubMed Web of Science ®Google Scholar
• PRICE R, LUXEMBURGER C, VAN VUGT M et al.: Artesu-nate and mefloquine in the treatment of uncompli-cated multidrug- resistant hyperparasitaemic falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. (1998) 92:207–211.
   Google Scholar
• LUXEMBURGER C, RICCI F, NOSTEN F, RAIMOND D, BATHET S, WHITE NJ: The epidemiology of severe malaria in an area of low transmission in Thailand. Trans. R. Soc. Trop. Med. Hyg. (1997) 91:256–262.
   PubMed Web of Science ®Google Scholar
• PRICE R, VAN VUGT M, NOSTEN F et al.: Artesunateversus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria. Am. J Trop. Med. Hyg. (1998) 59:883–888.
   PubMed Web of Science ®Google Scholar
• NOSTEN F, LUXEMBURGER C, TER KUILE FO et al.: Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination [published erratum appears in J Infect Dis 1995 Feb;1 71(2):51 9]. J. Infect. Dis. (1994) 170:971–977.
   Google Scholar
• BUNNAG D, VIRAVAN C, LOOAREESUWAN S, KARBWANG J, HARINASUTA T: Double blind random-ised clinical trial of oral artesunate at once or twice daily dose in falciparum malaria. Southeast AsianJ Trop. Med. Public Health (1991) 22:539–543.
   PubMedGoogle Scholar
• MISHRA SK, ASTHANA OP, MOHANTY S et al.: Effective-ness of alpha,beta-arteether in acute falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. (1995) 89:299–301.
   PubMed Web of Science ®Google Scholar
• PRICE RN, NOSTEN F, LUXEMBURGER C etal.: Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. (1995) 89:523–527.
   Google Scholar
• CHAWIRA AN, WARHURST DC, ROBINSON BL, PETERS W: The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice. Trans. R. Soc. Trop. Med. Hyg. (1987) 81 :554–558.
   PubMed Web of Science ®Google Scholar
• WHITE NJ: Assessment of the pharmacodynamic properties of antimalarial drugs in viva Antimicrob. Agents Chemother. (1997) 41:1413–1422.
   PubMed Web of Science ®Google Scholar
• WHITE N: Antimalarial drug resistance and combina-tion chemotherapy. Philos. Trans. R. Soc. fond. B. Biol. Sci. (1999) 354:739–749.
   PubMed Web of Science ®Google Scholar
• PETERS W, ROBINSON BL: The chemotherapy of rodent malaria. LVHI. Drug combinations to impede the selection of drug resistance, Part. 2: The new generation-artemisinin or artesunate with long-acting blood schizontocides [In Process Citation]. Ann. Trop. Med. Parasitol. (2000) 94:23–35.
   Google Scholar
• PRICE RN, NOSTEN F, LUXEMBURGER C et al: Effects of artemisinin derivatives on malaria transmissibility. Lancet (1996) 347:1654–1658.
   PubMed Web of Science ®Google Scholar
• DUTTA GP, BAJPAI R, VISHWAKARMA RA: Artemisinin (qinghaosu)-a new gametocytocidal drug for malaria. Chemotherapy (1989) 35:200–207.
   PubMed Web of Science ®Google Scholar
• NOSTEN F, VAN VUGT M, PRICE RN et al.: The effects of combining artesunate with mefloquine on the incidence of falciparum malaria and the evolution of drug resistance. Lancet (2000) (In Press).
   Google Scholar
• WHITE NJ, NOSTEN F, LOOAREESUWAN S et al.: Averting a malaria disaster. Lancet (1999) 353:1965–1967.
   PubMed Web of Science ®Google Scholar
• LOOAREESUWAN S, VIRAVAN C, VANIJANONTA S et al: Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet (1992) 339:821–824.
   PubMed Web of Science ®Google Scholar
• LOOAREESUWAN S, VIRAVAN C, VANIJANONTA S, WILAIRATANA P, PITISUTTITHUM P, ANDRIAL M: Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: two- and three-day regimens. Am. Trop. Med. Hyg. (1996) 54:210–213.
   PubMed Web of Science ®Google Scholar
• LUXEMBURGER C, TER KUILE FO, NOSTEN F et al: Single day mefloquine-artesunate combination in the treatment of multi- drug resistant falcip arum malaria. Trans. R. Soc. Trop. Med. Hyg. (1994) 88:213–217.
   PubMed Web of Science ®Google Scholar
• LOOAREESUWAN S, VANIJANONTA S, VIRAVAN C, WILAIRATANA P, CHAROENLARP P, ANDRIAL M: Randomized trial of mefloquine alone and artesunate followed by mefloquine for the treatment of acute uncomplicated falciparum malaria. Ann. Trop. Med. Parasitol. (1994) 88:131–136.
   PubMed Web of Science ®Google Scholar
• PRICE RN, NOSTEN F, LUXEMBURGER C et al: Artesu-nate/mefloquine treatment of multi-drug resistant falciparum malaria [published erratum appears in Trans R Soc Trop Med Hyg 1998 Jan - Feb;92(1):122]. Trans. R. Soc. Trop. Med. Hyg. (1997) 91:574–577.
   PubMed Web of Science ®Google Scholar
• PRICE R, SIMPSON JA, TEJA-ISAVATHARM P et al.: Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria. Antimicrob. Agents Chemother. (1999) 43:341–346.
   PubMed Web of Science ®Google Scholar
• VON SEIDLEIN L, JAFFAR S, PINDER M et al.: Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697. J Infect. Dis. (1997) 176:1113–1116.
   PubMed Web of Science ®Google Scholar
• VAN VUGT M, BROCKMAN A, GEMPERLI B et al.: Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug- resistant falciparum malaria. Antimicrob. Agents Chemother. (1998) 42:135–139.
   PubMed Web of Science ®Google Scholar
• VUGT MV, WILAIRATANA P, GEMPERLI B et al: Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. (1999) 60:936–942.
   PubMed Web of Science ®Google Scholar
• CHAWIRA AN, WARHURST DC: The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. J. Trop. Med. Hyg. (1987) 90:1–8.
   PubMed Web of Science ®Google Scholar
• DUARTE EC, FONTES CJ, GYORKOS TW, ABRAHA-MOWICZ M: Randomized controlled trial of artesunate plus tetracycline versus standard treatment (quinine plus tetracycline) for uncomplicated Plasmodium falciparum malaria in Brazil. Am. J. Trop. Med. Hyg. (1996) 54:197–202.
   PubMed Web of Science ®Google Scholar
• LOOAREESUWAN S, VIRAVAN C, VANIJANONTA S et al: Randomized trial of mefloquine-doxycycline and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. Am. J Trop. Med. Hyg. (1994) 50:784–789.
   PubMed Web of Science ®Google Scholar
• VON SEIDLEIN L, MILLIGAN P, PINDER M et al: Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet (2000) 355: 352–357.
   PubMed Web of Science ®Google Scholar
• DOHERTY JF, SADIQ AD, BAYO L et al: A randomized safety and tolerability trial of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncompli-cated malaria in Gambian children [In Process Citation]. Trans. R. Soc. Trop. Med. Hyg. (1999) 93:543–546.
   PubMed Web of Science ®Google Scholar
• NEWTON CR, KRISHNA S: Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol. Ther. (1998) 79:1–53.
   PubMed Web of Science ®Google Scholar
• MCINTOSH HM, OLLIARO P: Treatment of severe malaria with artemisinin derivatives. A systematic review of randomised controlled trials. Med. Trop. (1998) 58:61–62.
   Google Scholar
• SEATON RA, TREVETT AJ, WEMBRI JP et al: Randomized comparison of intramuscular artemether and intrave-nous quinine in adult, Melanesian patients with severe or complicated, Plasmodium falciparum malaria in Papua New Guinea. Ann. Trop. Med. Parasitol. (1998) 92:133–139.
   PubMed Web of Science ®Google Scholar
• MURPHY S, ENGLISH M, WARUIRU C et al.: An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. Trans. R. Soc. Trop. Med. Hyg. (1996) 90:298–301.
   PubMed Web of Science ®Google Scholar
• VAN HENSBROEK MB, ONYIORAH E, JAFFAR S et al.: A trial of artemether or quinine in children with cerebral malaria. N Engl. J Med. (1996) 335:69–75.
   PubMed Web of Science ®Google Scholar
• TRAN TH, DAY NP, NGUYEN HP et al.: A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malarias. N Engl. J Med. (1996) 335:76–83.
   PubMed Web of Science ®Google Scholar
• TAYLOR TE, WILLS BE, KAZEMBE P et al: Rapid coma resolution with artemether in Malawian children with cerebral malaria. Lancet (1993) 341:661–662.
   PubMed Web of Science ®Google Scholar
• HIEN TT, PHU NH, MAI NT et al.: An open randomized comparison of intravenous and intramuscular artesu-nate in severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. (1992) 86:584–585.
   PubMed Web of Science ®Google Scholar
• HIEN TT, ARNOLD K, VINH H et al.: Comparison of artemisinin suppositories with intravenous artesu-nate and intravenous quinine in the treatment of cerebral malaria. Trans. R. Soc. Trop. Med. Hyg. (1992) 86 :582–583.
   PubMed Web of Science ®Google Scholar
• HA V, NGUYEN NH, TRAN TB et al: Severe and compli-cated malaria treated with artemisinin, artesunate or artemether in Vietnam. Trans. R. Soc. Trop. Med. Hyg. (1997) 91:465–467.
   PubMed Web of Science ®Google Scholar
• NOSTEN F, VAN VUGT M, WHITE NJ: Intrarectalartemisinin derivatives. Med. Trop. (1998) 58:63–64.
   PubMedGoogle Scholar
• LI GQ, GUO XB, JIAN HX et al: Observation on theefficacy of qinghaosu suppository in 100 cases of falciparum malaria. J. Tradit. Chin. Med. (1985) 5:159–161.
   PubMedGoogle Scholar
• CAO XT, BETHELL DB, PHAM TP et al.: Comparison ofartemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria. Trans. R. Soc. Trop. Med. Hyg. (1997) 91:335–342.
   PubMed Web of Science ®Google Scholar
• LOOAREESUWAN S, WILAIRATANA P, MOLUNTO W, CHALERMRUT K, OLLIARO P, ANDRIAL M: A comparative clinical trial of sequential treatments of severe malaria with artesunate suppository followed by mefloquine in Thailand. Am. J. Trop. Med. Hyg. (1997) 57:348–353.
   PubMed Web of Science ®Google Scholar
• SABCHAREON A, ATTANATH P, CHANTHAVANICH P etal: Comparative clinical trial of artesunate supposito-ries and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria. Am. J. Trop. Med. Hyg. (1998) 58:11–16.
   PubMed Web of Science ®Google Scholar
• PRICE R, VAN VUGT M, PHAIPUN L et al.: Adverse effectsin patients with acute falciparum malaria treated with artemisinin derivatives. Am. J Trop. Med. Hyg. (1999) 60 :547–555.
   PubMed Web of Science ®Google Scholar
• KAMCHONWONGPAISAN S, MCKEEVER P, HOSSLER P, ZIFFER H, MESHNICK SR: Artemisinin neurotoxicity: neuropathology in rats and mechanistic studies in vitro. Am. J. Trop. Med. Hyg. (1997) 56:7–12.
   PubMed Web of Science ®Google Scholar
• BREWER TG, PEGGINS JO, GRATE SJ et al.: Neurotoxicityin animals due to arteether and artemether. Trans. R. Soc. Trop. Med. Hyg. (1994) 88 (Suppl. 1):S33–36.
   Google Scholar
• BREWER TG, GRATE SJ, PEGGINS JO et al.: Fatalneurotoxicity of arteether and artemether. Am. J Trop. Med. Hyg. (1994) 51:251–259.
   PubMed Web of Science ®Google Scholar
• MILLER LG, PANOSIAN CB: Ataxia and slurred speechafter artesunate treatment for falciparum malaria [letter] [see comments]. N Engl. J. Med. (1997) 336:1328.
   PubMed Web of Science ®Google Scholar
• ELIAS Z, BONNET E, MARCHOU B, MASSIP P: Neurotox-icity of artemisinin: possible counseling and treatment of side effects [In Process Citation]. Clin. Infect. Dis. (1999) 28:1330–1331.
   PubMed Web of Science ®Google Scholar
• NONTPRASERT A, NOSTEN-BERTRAND M, PUKRITTAY-AKAMEE S, VANIJANONTA S, ANGUS BJ, WHITE NJ: Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice. Am. J. Trop. Med. Hyg. (1998) 59:519–522.
   PubMed Web of Science ®Google Scholar
• GENOVESE RF, NEWMAN DB, PETRAS JM, BREWER TG: Behavioral and neural toxicity of arteether in rats. Pharmacol. Biochem. Behav. (1998) 60:449–458.
   PubMed Web of Science ®Google Scholar
• VAN VUGT M, ANGUS BJ, PRICE RN et al.: A case-control auditory evaluation of patients treated with artemisi-nin derivatives for multidrug-resistant Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. (2000) 62:65–69.
   PubMed Web of Science ®Google Scholar
• LI GQ, GUO XB, JIN R, WANG ZC, JIAN HX, LI ZY: Clinical studies on treatment of cerebral malaria with qinghaosu and its derivatives. J. Tradit. Chin. Med. (1982) 2:125–130.
   PubMedGoogle Scholar
• WANG TY: Follow-up observation on the therapeutic effects and remote reactions of artemisinin (Qinghaosu) and artemether in treating malaria in pregnant woman. J Tradit. Chin. Med. (1989) 9:28–30.
   PubMedGoogle Scholar
• CHINA CO-OPERATIVE RESEARCH GROUP: Chemical studies on qinghaosu (artemisinine). j Tradit. Chin. Med. (1982) 2:3–8.
   PubMedGoogle Scholar
• WORLD HEALTH ORGANISATION: The role of artemisi-nin and its derivatives in the current treatment of malaria. Report of an informal consultation, Geneva (1993).
   Google Scholar
• MCGREADY R, CHO T, CHO JJ et al.: Artemisinin deriva-tives in the treatment of falciparum malaria in pregnancy. Trans. R. Soc. Trop. Med. Hyg. (1998) 92:430–433.
   PubMed Web of Science ®Google Scholar
• MCGREADY R, NOSTEN F: The Thai-Burmese border: drug studies of Plasmodium falciparum in pregnancy [In Process Citation]. Ann. Trop. Med. Parasitol. (1999) 93 (Suppl. 1):S19–23.
   Google Scholar
• KAMCHONWONGPAISAN S, CHANDRA-NGAM G, AVERY MA, YUTHAVONG Y: Resistance to artemisinin of malaria parasites (Plasmodium falciparum) infecting alpha-thalassemic erythrocytes in vitro. Competition in drug accumulation with uninfected erythrocytes. J Clin. Invest. (1994) 93 :467–473.
   Web of Science ®Google Scholar
• YUTHAVONG Y, BUTTHEP P, BUNYARATVEJ A, FUCHAROEN S: Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes. j Clin. Invest. (1989) 83:502–505.
   PubMed Web of Science ®Google Scholar
• LUXEMBURGER C, BROCKMAN A, SILAMUT K et al.: Two patients with falciparum malaria and poor in vivo responses to artesunate. Trans. R. Soc. Trop. Med. Hyg. (1998) 92:668–669.
   PubMed Web of Science ®Google Scholar
• WONGSRICHANALAI C, NGUYEN TD, TRIEU NT et al.: Invitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials. Acta Trop. (1997) 63:151–158.
   PubMed Web of Science ®Google Scholar
• BASCO LK, LE BRAS J: In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am. J. Trop. Med. Hyg. (1993) 49:301–307.
   PubMed Web of Science ®Google Scholar
• GAY F, CICERON L, LITAUDON M et al.: In-vitro resistance of Plasmodium falciparum to qinghaosu derivatives in west Africa. Lancet (1994) 343:850–851.
   PubMed Web of Science ®Google Scholar
• REED MB, SALIBA KJ, CARUANA SR, KIRK K, COWMAN AF: Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature (2000) 403:906–909.
   PubMed Web of Science ®Google Scholar
• PRICE RN, CASSAR C, BROCKMAN A et al: The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Andmicrob. Agents Chemother. (1999) 43:2943–2949.
   PubMed Web of Science ®Google Scholar
• WONGSRICHANALAI C, WIMONWATTRAWATEE T, SOOKTO P et al.: In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand. Bull. World Health Organ. (1999) 77:392–398.
   PubMed Web of Science ®Google Scholar
• BROCKMAN A, PRICE RN, VAN VUGT M et al.: Plasmo-dium falciparum antimalarial drug susceptibility on the northwestern border of Thailand during five years of extensive artesunate-mefloquine use. Trans. R. Soc. Trop. Med. Hyg. (2000). (In Press).
   Google Scholar
• INSELBURG J: Induction and isolation of artemisinine-resistant mutants of Plasmodium falciparum. Am. J. Trop. Med. Hyg. (1985) 34:417–418.
   PubMed Web of Science ®Google Scholar
• MCINTOSH HM, OLLIARO P: Treatment of uncompli-cated malaria with artemisinin derivatives. A system-atic review of randomised controlled trials. Med. Trop. (1998) 58:57–58.
   Google Scholar
• POSNER GH, OH CH, GERENA L, MILHOUS WK: Extraor-dinarily potent antimalarial compounds: new, structurally simple, easily synthesized, tricyclic 1,2,4-trioxanes. J Med. Chem. (1992) 35:2459–2467.
   PubMed Web of Science ®Google Scholar